Viewing Study NCT06487468



Ignite Creation Date: 2024-07-17 @ 11:45 AM
Last Modification Date: 2024-10-26 @ 3:34 PM
Study NCT ID: NCT06487468
Status: COMPLETED
Last Update Posted: 2024-07-08
First Post: 2024-06-27

Brief Title: Risk Factors In Heart Failure Patients With Preserved Ejection Fraction
Sponsor: Xiangtan Central Hospital
Organization: Xiangtan Central Hospital

Study Overview

Official Title: A Study on Risk Factors in Heart Failure Patients With Preserved Ejection Fraction After Hospital Discharge
Status: COMPLETED
Status Verified Date: 2024-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: RIPE-HF
Brief Summary: This study aimed to identify the independent risk factors associated with heart failure readmission cardiac mortality and all-cause death among patients discharged from Xiangtan Central Hospital with heart failure and preserved ejection fraction HFpEF Understanding related risk factors might add future clinical decision making for individualized post discharge management of HFpEF patients aiming to improve the outcome of discharged HFpEF patients
Detailed Description: This study sought to determine the independent risk factors linked to endpoint events which include all-cause mortality or readmission for heart failure cardiovascular death among hospitalized patients with heart failure and preserved ejection fraction HFpEF at Xiangtan Central Hospital during the period from May 1 2014 to January 31 2023 The clinical follow up ended on January 31 2024 The study examined the risk factors associated with the endpoint outcome cardiovascular death and death from any cause and readmission due to heart failure to provide clinical evidence for intervening discharged HFpEF patients with the objective of improving patient outcomes in future clinical practice

The clinical features of hospitalized heart failure with preserved ejection fraction HFpEF EF50 are analyzed retrospectively by reviewing the patients demographic clinical data including patient medical history initial clinical evaluations and therapeutic interventions as well as echocardiographic data in the hospitals electronic health records and relevant databases The clinical outcome of enrolled patients are obtained through a team of three experienced cardiologists and twelve nursing professionals through outpatient consultations telephone follow-ups and community visit The primary endpoint events are all-cause mortality the second endpoints are the composite cardiovascular death and heart failure readmission

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None